Latest Manufacturing News

IDT Australia Limited has reported a significant narrowing of its half-year loss to $1.3 million, driven by stable revenues and operational efficiencies. The pharmaceutical manufacturer highlights growth in key segments despite some timing setbacks.

Cleo Diagnostics has chosen Bio-Techne’s next-generation Ella™ platform to enhance its ovarian cancer blood test, aiming for faster, more precise results and a streamlined path to FDA approval.

Schaffer Corporation’s first half FY26 profit fell sharply due to a Jaguar Land Rover cyberattack disrupting production, while its South Connect Jandakot property development breaks ground.

Schaffer Corporation Limited reported a significant 61% drop in net profit and a 17% decline in revenue for the half-year ended December 2025, impacted by operational disruptions and softer market conditions. Despite the downturn, the company declared a fully franked interim dividend of 45 cents per share.

INOVIQ Limited reported a $3.96 million net loss for H1 2026, driven by increased R&D spend, while securing $10.2 million to accelerate its exosome-based cancer diagnostics and therapeutics pipeline.

Step One Clothing reports a sharp revenue decline and a significant inventory write-down, posting a net loss in the first half of 2026. The company signals a strategic reset to regain momentum.

Euro Manganese Inc. reported progress on its Chvaletice and Bécancour manganese projects, securing funding amendments and advancing permitting despite ongoing financial pressures. The company is positioned to benefit from growing demand for high-purity manganese in lithium-ion batteries amid evolving market dynamics.

Southern Cross Electrical Engineering reported a strong half-year EBITDA growth of 30.8% despite a $46.1 million legal settlement impacting net profit. The company raised its full-year EBITDA guidance amid a robust project pipeline and ongoing diversification.

Fletcher Building reports a stable half-year performance despite subdued markets, advancing its strategic pivot with the announced sale of its Construction division.

Clever Culture Systems posted a $1.32 million loss for the half year ending December 2025, reflecting a strategic shift and reduced government grants. Despite this, the company strengthened its cash position, repaid government debt, and grew its APAS Independence instrument footprint globally.

Hydralyte USA has implemented targeted headcount reductions saving around US$25,000 monthly and completed manufacturing runs to resolve supply shortages, replenishing inventory with key distributors to support near-term sales growth.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.